Treosulfan Completed Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00491634Treosulfan-based Conditioning for Transplantation in AML/MDS
NCT01062490Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)